Israeli vascular-focused bio-engineering company Amnis Therapeutics said today it won Swedish approval for a 1st-in-human clinical trial of its Golden Retriever neuro thrombectomy device. The trial will be led by neurosurgeon Dr. Tommy Andersson, and is slated to enroll 60 acute ischemic stroke patients with large intracerebral vessel occlusion, the company said. “We are happy […]